
Don’t delay: Register now for INVEST Pop Health
Industry executives will share their insights at the INVEST Pop Health conference, held in collaboration with New Orleans Business Alliance, scheduled for November 15-16.
Industry executives will share their insights at the INVEST Pop Health conference, held in collaboration with New Orleans Business Alliance, scheduled for November 15-16.
In this webinar on Feb. 10, healthcare experts from Desert Oasis Healthcare and iRhythm Technologies will discuss how Zio monitors, designed to be worn for longer duration than holter monitors, represent a new standard of care in remote cardiac monitoring.
VivaLNK is currently developing a cardiac device, which is the centerpiece of a new platform with the capability to diagnose a-fibrillation more quickly and efficiently than traditional clinical standards.
Apple Watch's entry into the device world garnered a ton of attention and praise, but a good portion of observers have reservations about whether it will truly move the needle in healthcare.
Gilead Sciences has started a Phase II/III trial of its novel cardiac patch worn to monitor changes in arrhythmia.
California arrhythmia diagnostic company iRhythm Technologies has raised nearly $3.5 million, by issuing debt, options and warrants, according to a recent regulatory filing. San Francisco-based iRhythm makes the Zio Patch, a single-use, water-resistant, continuous cardiac rhythm monitoring device that can be worn for up to 14 days. It is meant to be an early diagnostic […]
St. Jude Medical’s partnership with a California-based arrhythmia-diagnostic company seems to be going well enough that it recently poured more money into that startup. In May 2010, the Little Canada, Minnesota-based company signed a co-branding and co-marketing relationship with San Francisco-based iRhythm Technologies Inc. and was the lead investor in iRhythm’s $10 million equity round. […]